Correction to “Abstracts of the 65th Annual Scientific Meeting of the British Society for Haematology”

Dettagli Bibliografici
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Haematology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Use of andexanet alfa: A British Society for Haematology position statement
di: Richard J. Buka, et al.
Pubblicazione: (2026)

Management of relapsed multiple myeloma: A British Society of Haematology and UK Myeloma Society guideline
di: Matthew Jenner, et al.
Pubblicazione: (2025)

Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline
di: Austin Kulasekararaj, et al.
Pubblicazione: (2024)

Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update
di: Katie Hands, et al.
Pubblicazione: (2024)

Guideline for the Management of Conception and Pregnancy in Thalassaemia Syndromes: A British Society for Haematology Guideline
di: Farrukh T. Shah, et al.
Pubblicazione: (2024)

Management of relapsed or refractory large B‐cell lymphoma: A British Society for Haematology Guideline
di: Sridhar Chaganti, et al.
Pubblicazione: (2025)

Prevention and treatment of infection in patients with an absent or hypofunctional spleen: A British Society for Haematology guideline
di: Shamez N. Ladhani, et al.
Pubblicazione: (2024)

Clinical management of bispecific antibody therapy for lymphoma: A British Society for Haematology Good Practice Paper
di: Sridhar Chaganti, et al.
Pubblicazione: (2025)

Investigation and management of thrombocytosis without JAK2 , CALR or MPL mutations: A British Society for Haematology Guideline
di: Anna L. Godfrey, et al.
Pubblicazione: (2025)

Challenging situations in patients with cancer‐associated thrombosis—Further clarification required in the British Society for Haematology guidelines—Response
di: Raza Alikhan, et al.
Pubblicazione: (2024)

The British Journal of Haematology celebrates its 70th birthday. Part one: Malignant haematology 2018–2024
di: Arnold Ganser
Pubblicazione: (2025)

Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics: A British Society for Haematology Guideline
di: Mamta Garg, et al.
Pubblicazione: (2026)

Diagnosis and initial treatment of transplant‐eligible high‐risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper
di: Martin Kaiser, et al.
Pubblicazione: (2024)

Prevention and management of indwelling catheter‐related thrombosis in sickle cell disease and thalassaemia: A British Society for Haematology Good Practice Paper
di: George Woodward, et al.
Pubblicazione: (2024)

British Society for Haematology updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children with haematological malignancies: A focus on patient safety
di: Y. L. Tracey Chan, et al.
Pubblicazione: (2025)

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper
di: Aisling Barrett, et al.
Pubblicazione: (2024)

Laboratory investigation and clinical management of acquired coagulation factor inhibitors: A joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline
di: Charles Percy, et al.
Pubblicazione: (2025)

Guideline for the management of hepatitis B and C infection and subsequent liver disease surveillance (where indicated) in people with congenital bleeding disorders: A joint guideline from the British Society of Haematology and the British Viral Hepatitis Group
di: Ashley Brown, et al.
Pubblicazione: (2025)

Immune repertoire profiling in immune thrombocytopenia: A path towards biomarkers, for The British Journal of Haematology
di: Amna Malik, et al.
Pubblicazione: (2026)

20th Annual Sickle Cell & Thalassaemia Conference
Pubblicazione: (2025)

‘Medical Haematology’ via systems‐based haematology
di: Richard C. Godby, et al.
Pubblicazione: (2026)

Current gynaecological management of women and girls with bleeding disorders in the United Kingdom : A UKHCDO haemophilia treatment centre survey and evaluation of real‐world clinical practice for the British Journal of Haematology
di: Laura Knox, et al.
Pubblicazione: (2025)

Correctly marking the 70th anniversary of Castleman disease
di: Sanya Sukpanichnant
Pubblicazione: (2024)

Abstracts
Pubblicazione: (2025)

UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT ): Best practice consensus guidelines from the British Society for Blood and Marrow Transplant and Cellular Therapies ( BSBMTCT ), NHS England Genomic Laboratory Hub ( GLH ) Haematological Malignancies Working Group, UK Cancer Genetics Group ( UKCGG ) and the UK National External Quality Assessment Service for Leucocyte Immunophenotyping ( UK NEQAS LI )
di: Andrew Clark, et al.
Pubblicazione: (2025)

Oral Abstracts
Pubblicazione: (2024)

Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders
di: S. Ghorashian, et al.
Pubblicazione: (2025)

Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20‐year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)
di: Majid Kazmi, et al.
Pubblicazione: (2025)

COVID ‐19‐related mortality in a real‐world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK 's Haematological Malignancy Research Network
di: Alexandra Smith, et al.
Pubblicazione: (2025)

Outcomes and risk factors for complications in deletional haemoglobin H disease: A retrospective longitudinal cohort study in British Columbia, Canada
di: Jacqueline Blunt, et al.
Pubblicazione: (2025)

Taiwan consensus on pulmonary chronic graft‐versus‐host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation ( TBMT ) and Taiwan Society of Pulmonary and Critical Care Medicine ( TSPCCM )
di: Xavier Cheng‐Hong Tsai, et al.
Pubblicazione: (2025)

Bone mineral density and vertebral fractures in teenage and young adult patients with acute lymphoblastic leukaemia and lymphoblastic lymphoma: A report from the British OsteoNecrosis Study ( BONES )
di: Aidan Kirk, et al.
Pubblicazione: (2025)

Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS‐SFB31
di: Linlin Liu, et al.
Pubblicazione: (2024)

Correction to ‘A phase II study of ibrutinib in combination with ixazomib in patients with Waldenstrom macroglobulinaemia’
Pubblicazione: (2024)

Correction to “Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma”
Pubblicazione: (2025)

Correction to “Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients”
Pubblicazione: (2024)

Correction to ‘Genetic testing to identify hereditary predispositions to haematological malignancy is critical prior to allogenic haematopoietic cell transplant’
Pubblicazione: (2025)

Correction to Bone Marrow Stroma Protects Myeloma Cells From Cytotoxic Damage via Induction of the Oncoprotein MUC1
Pubblicazione: (2024)

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy
di: Takaaki Konuma, et al.
Pubblicazione: (2025)

Can we move beyond myeloablative conditioning ( MAC )? A comparison of MAC versus reduced intensity conditioning ( RIC ) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG ‐ PTCy ‐ CSA for GVHD prophylaxis
di: Ruah Alyamany, et al.
Pubblicazione: (2025)

Documenti analoghi

Documenti analoghi